Canadian Online Pharmacy

CDER New February 14, 2014

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

February 13, 2014


New and Generic Drug Approvals

February 12, 2014

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Bacteriostatic Sodium Chloride 0.9% In Plastic Container sodium chloride Injectable;Injection Hospira Manufacturing Change or Addition
Chloraprep One-Step chlorhexidine gluconate; isopropyl alcohol Sponge;Topical Carefusion Manufacturing Change or Addition
Chloraprep One-Step Frepp chlorhexidine gluconate; isopropyl alcohol Sponge;Topical Carefusion Manufacturing Change or Addition
Chloraprep With Tint chlorhexidine gluconate; isopropyl alcohol Sponge;Topical Carefusion Manufacturing Change or Addition
Curosurf poractant alfa Suspension;Intratracheal Cornerstone Therap Manufacturing Change or Addition
Fluorescite fluorescein sodium Injectable;Intravenous Alcon Pharms Ltd Manufacturing Change or Addition
Imbruvica ibrutinib Capsule;Oral Pharmacyclics Inc Approval
Isopto Carpine pilocarpine hydrochloride Solution;Ophthalmic Alcon Res Manufacturing Change or Addition
Janumet Xr metformin hydrochloride; sitagliptin phosphate Tablet, Extended Release;Oral Merck Sharp Dohme Labeling Revision
Renacidin citric acid; gluconolactone; magnesium carbonate Solution;Irrigation United Guardian Manufacturing Change or Addition
Simponi Aria golimumab Injectable; Injection Janssen Biotech Labeling Revision
Sodium Chloride 0.9% In Plastic Container sodium chloride Injectable;Injection Hospira Manufacturing Change or Addition
Sodium Chloride In Plastic Container sodium chloride Injectable;Injection Hospira Manufacturing Change or Addition
Technelite technetium tc-99m sodium pertechnetate generator Solution;Injection, Oral Lantheus Medcl Labeling Revision
Temozolomide temozolomide Capsule; Oral Sun Pharma Global Approval
Timentin clavulanate potassium; ticarcillin disodium Injectable;Injection Glaxosmithkline Manufacturing Change or Addition
Xarelto rivaroxaban Tablet; Oral Janssen Pharms Labeling Revision
Zyrtec-D 12 Hour cetirizine hydrochloride; pseudoephedrine hydrochloride Tablet, Extended Release;Oral Mcneil Manufacturing Change or Addition

 


This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery